In letter to PM, Cong's Tagore questions logic behind decision to hike prices of 8 essential drugs
Congress MP Manickam Tagore writes to PM Modi, expressing concern over NPPA's decision to hike prices of eight essential drugs by 50%. Tagore urges for an independent review committee to assess the impact on patients and healthcare, emphasizing th...

"While I understand that the government cited 'extraordinary circumstances' and 'public interest' as reasons for this increase, I believe it is crucial to clarify the rationale behind such a significant decision," the Congress MP from Tamil Nadu's Virudhunagar said.
"This price hike affects vital medications for conditions like asthma, tuberculosis, bipolar disorder, and glaucoma, which are essential for millions of citizens," Tagore said.
Many patients and their families already face financial challenges in accessing necessary treatments, he said.
A sudden increase in medicine prices can place an additional burden on these individuals, potentially compromising their health outcomes, Tagore said.
"I urge the government to provide a more detailed explanation of the extraordinary circumstances that necessitated this price hike. Furthermore, I propose the establishment of an independent review committee to assess the real impact of this increase on patients and healthcare providers," he said in the letter dated October 25.
Such a committee could offer recommendations for future pricing policies that balance industry viability with public health needs, he said.
"Transparency in this decision-making process is vital to maintaining public trust. A thorough review could lead to informed policies ensuring that essential medicines remain affordable and accessible for all," Tagore asserted.
"I look forward to your response and hope for a resolution that prioritises the wellbeing of our citizens," the Congress leader said.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.